<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-clomipramine-hydrochloride-capsules.xml</id>
  <title>Recalls Watch: Clomipramine Hydrochloride Capsules</title>
  <link rel="self" href="https://recalls.watch/feed/substance-clomipramine-hydrochloride-capsules.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2025-11-12T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/97856/</id>
    <title>Zydus Pharmaceuticals (USA) Inc: clomiPRAMINE Hydrochloride and 2 more</title>
    <link href="https://recalls.watch/recall/fda/97856/"/>
    <updated>2025-11-12T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97159/</id>
    <title>Lupin Pharmaceuticals Inc.: clomiPRAMINE Hydrochloride Capsules USP 25 mg</title>
    <link href="https://recalls.watch/recall/fda/97159/"/>
    <updated>2025-07-30T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96681/</id>
    <title>Lupin Pharmaceuticals Inc.: clomiPRAMINE hydrochloride Capsules USP</title>
    <link href="https://recalls.watch/recall/fda/96681/"/>
    <updated>2025-04-30T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during 18-month long term stability study.</summary>
  </entry>
</feed>
